4 David Einhorn Coya Therapeutics Trades
David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $7.91 Million. That's 0.36% of their equity portfolio (25th largest holding). The investor owns 7.16% of the outstanding Coya Therapeutics stock. David Einhorn acquired their 1.27 Million shares between 2022 and 2023. So far they never sold any shares in the company. The stake costed the investor $6.6 Million, netting the investor a gain of 20% so far.
Avg closing price
Price range
Increased shares by 172.2% (+806 Thousand shares)
Q4 2023
Avg closing price
$5.55
Price range
$3.30
-
$7.59
Increased shares by 19.2% (+75.4 Thousand shares)
Q3 2023
Avg closing price
$3.98
Price range
$3.32
-
$5.08
Increased shares by 0.1% (+203 shares)
Q1 2023
Avg closing price
$4.37
Price range
$3.85
-
$4.93
New holding (+392 Thousand shares)
Q4 2022
Avg closing price
$4.65
Price range
$4.57
-
$4.74
